FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
National Lab Reporter
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Subscribe today for access to
Articles and Reports
Meeting the Needs of Laboratory Learners
The CDC’s OneLab training initiative offers free courses, events, resources, and networking opportunities for clinical lab professionals
Electronic Prior Authorization Bill Reintroduced in Congress
For clinical labs, the proposed law could bring more consistency to test ordering
FDA Resounds the Alarm on Biotin Test Interference
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Genetic Testing: CMS Proposes Expanding NGS Testing Eligibility
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
CLIA: CMS Revises State Operations Manual for Labs
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Hospital Labs: CMS Pushes Forward with Controversial Price Transparency Rules
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
The Year in Labs Regulation: The 6 Biggest Stories of 2019
"May you live...
Alabama Doctors, Cardio Practice, Settle Genetic Testing Kickback Claims for $1.1 Million
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Pay rates, vacations while recovering, gig economy
Department of Labor enters final stage of update to ‘regular rate’ rule under FLSA. As we have discussed previously in these updates, the Department of Labor has been working to update the definition
New Laws: Proposed Kickback Changes Would Provide Needed Relief But Also Largely Exclude Labs
In what could be the most significant story in health care fraud and abuse compliance of the past several years, the CMS and OIG proposed new rules (the Proposal) to adapt 20th century kickback laws to 21st century market conditions,
New Product Development: FDA Issues Final Guidance on IVD Oncology Trials
On Oct. 10, 2019, the FDA finalized guidance on an optional streamlined submission process to determine whether
CMS Delays Controversial Hospital Price Transparency Rules
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here